Advertisement

Pharmacy World & Science

, 30:810 | Cite as

Post-discharge medication reviews for patients with heart failure: a pilot study

  • Anne Ponniah
  • Sepehr Shakib
  • Christopher J. Doecke
  • Merelyn Boyce
  • Manya AngleyEmail author
Research Article

Abstract

Background Medication misadventure is greatest at times of change such as the transition from hospital to community. Patients with heart failure are prone to medication misadventure due to polypharmacy, inappropriate medication use and frequent readmissions. Objective To identify the barriers encountered when implementing a Liaison Pharmacist facilitated post-discharge medication management service for patients with heart failure. Method A Liaison Pharmacist contacted the patient’s General Practitioner (GP), sent them a medication discharge summary and organised an appointment for the patient with the GP approximately 2 days post-discharge to make a Home Medicines Review (HMR) referral. The patient’s community pharmacist was also contacted, sent a medication discharge summary and requested to engage an accredited pharmacist to undertake the HMR. The Liaison Pharmacist arranged for the HMR report to be sent to the outpatient department clinic to enable assessment of outcomes at the outpatient department follow-up 12 weeks post-discharge. Main outcome measure: GP HMR referral rates. Results 90 patients were offered the service. Fifty-nine patients (66%) agreed to have their GP contacted with 56 GPs agreeing to order a HMR and 41 patients having an HMR post-discharge. Barriers to the implementation of a HMR post-discharge included: patient withdrawal, low GP awareness of the HMR process and conducting the HMR in a timely manner. Conclusion This study provides evidence for the feasibility of a post-discharge pharmacy service for patients with heart failure although barriers to implementation have been identified.

Keywords

Australia Care transition Continuity of care Heart failure Liaison pharmacist Medication management Medication review Seamless care 

Notes

Acknowledgements

The assistance provided throughout the project by Ms. Olimpia Nigro, Senior Clinical Pharmacist, Royal Adelaide Hospital, is acknowledged with gratitude.

Funding

This study was supported by the Sansom Institute, University of South Australia and the Royal Adelaide Hospital.

Conflict of interest

None declared

References

  1. 1.
    Campbell DJ. Heart failure: how can we prevent the epidemic? Med J Aust. 2003;179:422–5.PubMedGoogle Scholar
  2. 2.
    Bennett A, Brien J. Community liaison pharmacist role in the multi-disciplinary care of heart failure patients. Aust J Pharm. 2002;83:740–3.Google Scholar
  3. 3.
    Varma S, McElnay J, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19:861–9.CrossRefGoogle Scholar
  4. 4.
    Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158:1067–72.PubMedCrossRefGoogle Scholar
  5. 5.
    Bennett A, Krass I, Brien J. The future burden of cardiovascular disease: what can pharmacists do? Aust J Pharm. 2005;86:166–9.Google Scholar
  6. 6.
    Michalsen A, Konig G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. 1998;80:437–41.PubMedGoogle Scholar
  7. 7.
    Bennett A, Brien J. Community liaison pharmacist role in the multi-disciplinary care of heart failure patients. Aust J Pharm. 2002;83:740–3.Google Scholar
  8. 8.
    Australian Pharmaceutical Advisory Council. National guidelines to achieve the continuum of quality use of medicines between hospital and community. Canberra: Australian Pharmaceutical Advisory Council, Commonwealth Department of Health and Aged Care; 1998.Google Scholar
  9. 9.
    Australian Pharmaceutical Advisory Council. Guiding principles to achieve continuity in medication management. Canberra: Australian Pharmaceutical Advisory Council, Commonwealth Department of Health and Aged Care; 2005.Google Scholar
  10. 10.
    Wilson S, Ruscoe W, Chapman M, Miller R. General practitioner-hospital communications: a review of discharge summaries. J Qual Clin Pract. 2001;21(4):104–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Australian Council for Safety and Quality in Health Care. Second national report on patient safety: improving medication safety, (Roughead L and Semple S). Canberra: Australian Council for Safety and Quality in Health Care; 2002.Google Scholar
  12. 12.
    Katz E, Nicod P, Brunner HR, Waeber B. Changes in treatment during and after hospitalization in patients taking drugs for cardiovascular diseases. Cardiovasc Drugs Ther. 1996;10(2):189–92.PubMedCrossRefGoogle Scholar
  13. 13.
    Koecheler JA, Abramowitz PW, Swin SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm. 1989;46(4):729–32.PubMedGoogle Scholar
  14. 14.
    Stowasser DA, McGuire TM, Petrie GM, Lauchlan RL, Collins D. Information quality: a major consideration in the development of medication liaison services. Aust J Hosp Pharm. 1997;27:362–6.Google Scholar
  15. 15.
    McGuire TM. A pharmaceutical care liaison model. Aust J Hosp Pharm. 1996;26:36–7.Google Scholar
  16. 16.
    Gilbert A, Roughead E, Beilby J, Mott K, Barratt J. Collaborative medication management services; improving patient care. Med J Aust. 2002;177:189–92.PubMedGoogle Scholar
  17. 17.
    Hargraves T, Bennett AA, Brien JE. Evaluating outpatient pharmacy services: a literature review of specialist heart failure services. Int J Pharm Pract. 2006;14:3–9.CrossRefGoogle Scholar
  18. 18.
    Emblen G, Miller E. Home medicines review: the how and why for GPs. Aust Fam Physician. 2004;33(1/2):49–51.PubMedGoogle Scholar
  19. 19.
    Jaeschke D, Close A, Edwards S, Pecanek H. HMR online resource kit. Pharmacy Guild of Australia and Divisions of General Practice Limited. 2004. http://mail.andgp.org.au/hmr/. Viewed 18 May 2006
  20. 20.
    Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting: a systematic review of the literature 1990–2002. University of South Australia; 2003.Google Scholar
  21. 21.
    Ponniah A, Anderson B, Shakib S, Doecke C, Angley M. Pharmacists’ role in the post-discharge management of patients with heart failure—a literature review. J Clin Pharm Ther. 2007;32:1–10.CrossRefGoogle Scholar
  22. 22.
    Holland R, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, et al. Effectiveness of visits from community pharmacists for patients with heart failure: Heart Med randomised controlled trial. BMJ (online). 2007. doi: 10.1136/bmj.39164.568183.AE.
  23. 23.
    Yu K, Nguyen A, Shakib S, Doecke C, Boyce M, March G, et al. Enhancing continuity of care: development of a post-discharge home medicines review model. J Pharm Pract Res. 2007;37(1):22–6.Google Scholar
  24. 24.
    Royal Adelaide Hospital. Royal Adelaide Hospital. Adelaide. 2006. <http://www.rah.sa.gov.au/homepage.php>. Viewed 10 October 2006.
  25. 25.
    Holland R, Lenghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomized controlled trial. BMJ. 2005;330(7486):293.PubMedCrossRefGoogle Scholar
  26. 26.
    Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323:1340.PubMedCrossRefGoogle Scholar
  27. 27.
    Petty DR, Knapp P, Raynor DK, House AO. Patients’ views of a pharmacist-run medication review clinic in general practice. Br J Gen Pract. 2003;53(493):607–13.PubMedGoogle Scholar
  28. 28.
    Petty DR, Zermansky AG, Raynor DK. ‘No thank you’: why elderly patients declined to participate in a research study. Pharm World Sci. 2001;23:22–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Emerson L. HMRs—the next five years? Pharm Rev. 2005;29(2):36–9.Google Scholar
  30. 30.
    Grimmer K, Hedges G, Moss J. Staff perceptions of discharge planning: a challenge for quality improvement. Aust Health Rev. 1999;22(3):95–109.Google Scholar
  31. 31.
    Seston EM, Tully MP, Cantrill J. Barriers to the implementation of pharmacist-run prescription monitoring and review services. Pharm J. 1999;263(7063):12–3.Google Scholar
  32. 32.
    Cochrane R, Mandal A, Ledger-Scott M, Walker R. Changes in drug treatment after discharge from hospital in geriatric patients. BMJ. 1992;305:694–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Frankyl SE, Breeling JL, Goldman L. Preventability of emergent hospital readmissions. Am J Med. 1991;90:667–74.Google Scholar
  34. 34.
    Gowan J, Roller L. Chronic disease self management and home medicines reviews. Aust J Pharm. 2004;85:131–3.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Anne Ponniah
    • 1
  • Sepehr Shakib
    • 2
  • Christopher J. Doecke
    • 3
  • Merelyn Boyce
    • 4
  • Manya Angley
    • 5
    Email author
  1. 1.University of South AustraliaAdelaideAustralia
  2. 2.Royal Adelaide HospitalAdelaideAustralia
  3. 3.Royal Adelaide Hospital, School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia
  4. 4.SA Divisions of General Practice IncorporatedWayvilleAustralia
  5. 5.Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia

Personalised recommendations